ClinicalTrials.Veeva

Menu

Cardiac MRI in Ischemic Stroke Study (CaMriSS)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Completed

Conditions

Stroke

Study type

Observational

Funder types

Other

Identifiers

NCT01917955
EA4/073/10 (Other Identifier)
CaMriSS_CSB

Details and patient eligibility

About

The purpose of this prospective single-center trial is to compare the safety and diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging and transesophageal echocardiography in patients with acute ischemic stroke.

Full description

Primary safety objective: Contrast medium-enhanced cardiac magnetic resonance imaging is safe in patients with acute ischemic stroke. Primary outcome: The diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging is comparable to transesophageal echocardiography in patients with acute ischemic stroke.

Enrollment

103 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with acute ischemic stroke detected by brain magnetic resonance imaging.

Exclusion criteria

  • Known atrial fibrillation or cardiac source of embolism
  • Severe aphasia
  • Acute infection or chronic inflammation
  • Severe arteriosclerosis or stenosis of brain-supplying arteries
  • Contraindications for magnetic resonance imaging or transesophageal echocardiography.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems